TrialLancet (London, England)2002

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

Mette Zander et al.PubMed ↗Publisher ↗

No numbers read from the abstract.